Home / Lorazepam / United States
US ATC N05BA06 · updated 2 Nov 2026
Lorazepam shortage in United States
Is there a Lorazepam shortage in United States?
Yes. As of 2 Nov 2026, 11 Lorazepam products are reported short in United States, the first since 3 May 2018. No return date has been given. Main reason: increased demand.
Also short in Canada, Italy, Spain, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02) | Fresenius Kabi USA, LLC | 3 May 2018 | not given | Not stated |
| US | Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1) | Amphastar Pharmaceuticals, Inc. | 3 May 2018 | not given | Not stated |
| US | Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30) limited | Hospira, Inc., a Pfizer Company | 3 May 2018 | not given | Increased demand Demand increase for the drug |
| US | Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10) | Hikma Pharmaceuticals USA, Inc. | 3 May 2018 | not given | Other |
| US | Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25) limited | Hikma Pharmaceuticals USA, Inc. | 5 Sep 2018 | not given | Increased demand Demand increase for the drug |
| US | Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10) | Hikma Pharmaceuticals USA, Inc. | 5 Sep 2018 | not given | Other |
| US | Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25) limited | Hikma Pharmaceuticals USA, Inc. | 5 Sep 2018 | not given | Increased demand Demand increase for the drug |
| US | Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10) | Hikma Pharmaceuticals USA, Inc. | 5 Sep 2018 | not given | Other |
| US | Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25) limited | Hikma Pharmaceuticals USA, Inc. | 5 Sep 2018 | not given | Increased demand Demand increase for the drug |
| US | Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10) | Hikma Pharmaceuticals USA, Inc. | 5 Sep 2018 | not given | Other |
| US | Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25) limited | Hikma Pharmaceuticals USA, Inc. | 5 Sep 2018 | not given | Increased demand Demand increase for the drug |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).